• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    American Resources Corporation - Class A Common Stock (NQ: AREC )

    1.070 +0.010 (+0.94%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about American Resources Corporation - Class A Common Stock

    < Previous 1 2 Next >
    Earnings Scheduled For November 14, 2024
    Via Benzinga
    Exploring American Res's Earnings Expectations
    Via Benzinga
    What's Going On With American Resources Stock Wednesday?
    American Resources announced that its subsidiary ReElement Technologies has been approved and certified for its Military Critical Technical Data Agreement. 
    Via Benzinga
    AREC Stock Earnings: American Res Misses EPS, Misses Revenue for Q2 2024
    AREC stock results show that American Res missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    AREC Stock Earnings: American Res Beats EPS, Misses Revenue for Q1 2024
    AREC stock results show that American Res beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    7 Penny Stocks That Could 5X by the End of 2024
    These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold. 
    Via InvestorPlace
    AREC Stock Earnings: American Res Misses EPS, Misses Revenue for Q4 2023
    AREC stock results show that American Res missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Recap: American Res Q4 Earnings
    Via Benzinga
    American Res Earnings Preview
    Via Benzinga
    American Res's Earnings: A Preview
    Via Benzinga
    AREC Well-Funded To Develop Carbon And Rare Earth Concentrates: Analyst
    H.C. Wainwright analyst Heiko F. 
    Via Benzinga
    Earnings Scheduled For March 28, 2024
    Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
    Via Benzinga
    Top 3 Christmas Stocks to Buy Before the Holiday Season Surge
    These top Christmas stocks for the upcoming holiday season will allow for any investors' portfolio to surge in value. 
    Via InvestorPlace
    4 Analysts Have This to Say About American Res
    Via Benzinga
    American Resources Rejects $260M Unsolicited Bid For American Carbon
    American Resources Corp (NASDAQ: AREC) revealed that it  
    Via Benzinga
    HC Wainwright & Co. Maintains Buy Rating for American Res: Here's What You Need To Know
    Via Benzinga
    American Resources's Earnings Outlook
    Via Benzinga
    American Resources Corp's (NASDAQ: AREC) ReElement to Transform Rare Earth and Battery Metals Industry and Help the World Counter China's Dominance
    American Resources Corp's (NASDAQ: AREC) ReElement to Transform Rare Earth and Battery Metals Industry and Help the World Counter China's Dominance 
    Via News Direct
    Topics Economy Electric Vehicles
    Exposures Economy Electric Vehicles
    Context Therapeutics And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
    The Dow Jones closed higher by more than 370 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    ReWalk Robotics, American Resources And These 2 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed higher on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
    Via Benzinga
    American Resources Earnings Perspective: Return On Capital Employed
    Via Benzinga
    Earnings Scheduled For May 16, 2022
    Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
    Via Benzinga
    Dow Jumps Over 300 Points; S&P 500 Rises 1%
    U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday. 
    Via Benzinga
    Earnings Scheduled For November 15, 2022
    Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million. 
    Via Benzinga
    Hurry! 7 Pitiful Stocks to Sell Before 2022 Ends
    Although it’s not great energy to be a “hater,” the reality is that some stocks to sell must be exited from your portfolio. 
    Via InvestorPlace
    Nasdaq Down Over 1%; Crude Oil Rises Sharply
    U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. 
    Via Benzinga
    4 Stocks Under $2 Insiders Are Aggressively Buying
    US stock futures traded higher this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
    Via Benzinga
    53 Biggest Movers From Yesterday
    Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing... 
    Via Benzinga
    Earnings Scheduled For August 15, 2022
    Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
    Via Benzinga
    36 Stocks Moving In Thursday's Mid-Day Session
    Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with... 
    Via Benzinga
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.